FINANCIALS
|
Remuneration report
The Remuneration Committee determines and monitors executive remuneration for the company. This it does through adherence to the company's Executive Remuneration Policy, which is to:
- attract, reward and retain executives of the highest calibre;
- align the behaviour and performance of executives with the company's strategic goals, in the overall interests of shareholders;
- ensure the appropriate mix of short, medium and long-term rewards and incentives, with the latter being closely linked to structured company performance targets and strategic objectives; and
- ensure that regional management is competitively rewarded within a global remuneration policy, which recognises both local and global markets.
In particular the Remuneration Committee is responsible for:
- the remuneration packages for executive directors of the company including, but not limited to, basic salary, performance-based short and long-term incentives, pensions, and other benefits; and
- the design and operation of the company's executive share option and other incentive schemes.
Membership of the Remuneration Committee
At the commencement of 2004, the following non-executive directors were members of the committee:
- Russell Edey (chairman);
- Colin Brayshaw;
- Nicky Oppenheimer;
- Julian Ogilvie Thompson; and
- Tony Trahar.
Messrs Oppenheimer and Ogilvie Thompson retired from the board of AngloGold Ashanti on 29 April 2004 and from all board committees.
Five meetings of the Remuneration Committee were held in 2004. Noting the resignation of Messrs Oppenheimer and Ogilvie Thompson during the year, attendance by members at meetings was as follows:
| Number of
meetings held | Number
attended |
| CB Brayshaw | 5 | 5 |
| RP Edey | 5 | 5 |
| NF Oppenheimer | 3 | 2 |
| J Ogilvie Thompson | 3 | 3 |
| AJ Trahar | 5 | 4 |
All meetings of the committee are attended by the chief executive officer and executive officer: human resources, except when their own remuneration or benefits are being discussed. The services of Deloitte & Touche are retained to act as independent, expert advisers on executive remuneration.
The following principles are applied in determining executive remuneration:
- Annual remuneration should be a combination of base pay and short, medium and long-term incentives, with salary comprising not more than 50% of annual remuneration.
- Salary should be set at the median for the relevant markets.
- All incentive plans should align performance targets with shareholder interests.
Executive director remuneration currently comprises the following elements:
- Basic salary, which is subject to annual review by the Remuneration Committee and is set at the median of salaries in similar companies in the relevant markets both in South Africa and globally. The individual salaries of executive directors are reviewed annually in light of their own performance, experience, responsibility and company performance.
- Annual bonus, which is determined by the achievement of a set of stretching company and individual performance targets. The company targets include earnings per share, cost control and global production. The weighting of the respective contribution of company and individual targets is 70% for company and 30% for individual. Failure to achieve safety improvement targets results in the reduction of bonuses for executive directors.
- Share incentive scheme, which allows for an annual grant of AngloGold Ashanti share options based on the achievement of pre-determined performance targets similar to those used for the annual bonus. Options granted are subject to the achievement of a performance condition set by the Remuneration Committee and are subject to a maximum equivalent to one times' annual salary for any executive director.
- Pensions: all executive directors are members of the AngloGold Ashanti Pension Fund, a defined benefit fund which guarantees a pension on retirement equivalent to 2% of final salary per year of service. Death and disability cover reflects best practice among comparable employers in South Africa.
- Other benefits: Executive directors are members of Discovery Health, which covers the director and his immediate family.
All executive directors hold service contracts that are reviewed and renewed annually. None of the service contracts have conditions which, on termination, provide for salary or benefit payments, whether in cash or in kind, in excess of one year.
Following additional research conducted by Deloitte & Touche on behalf of AngloGold Ashanti, the committee has recommended the discontinuation of the current share incentive scheme and the introduction of a bonus share plan (BSP) with effect from 2005. The options which have been granted under the scheme will remain subject to the conditions under which they were granted. As noted in last year's report, an investigation was also conducted into the introduction of a long-term incentive plan (LTIP).
The Remuneration Committee has therefore recommended the introduction of a BSP and LTIP, subject to shareholder approval at the annual general meeting to be held in 2005. The main reason for these proposed changes to executive incentive plans is that the current option scheme does not provide sufficient linkage between the interests of shareholders and the efforts of executives or managers. There is also little correlation between the efforts of executives and the success of the option scheme.
Bonus share plan
Participants in the bonus share plan will receive an annual bonus, part of which is paid in cash and part in shares, subject to the performance targets of the plan being achieved. The share element vests after three years, providing the participant is still in the company's employment at that time.
This will provide senior employees with a real stake in the company, unlike share options, where vesting is dependent on factors outside of their control. The vesting period of three years should also act as an incentive for employees to stay with the company.
Long-term incentive plan
The Remuneration Committee proposes the introduction of an LTIP for the most senior executives and managers in the company. The scheme will reward participants through the granting of shares for the achievement of stretched performance targets over a three-year period. These targets will be based on the performance of earnings per share (EPS) and relative total shareholder return (TSR), whereby the company will need to outperform its gold company peers consistently. Additionally, strategic business objectives will also need to be met, such as the successful integration of Ashanti into AngloGold.
Executive directors' and executive officers' remuneration
| | | | | | Pre-tax | |
| | Per- | Pension | | | gains on | |
| | formance- | scheme | | | share | |
| All figures have been stated | | related | contri- | Other | Sub | options | |
| to the nearest R000 | Salary | payments(1) | butions | benefits(2) | total | exercised | Total |
| Executive directors' remuneration 2004 |
| RM Godsell (chief executive officer) | 5,641 | 2,002 | 825 | 162 | 8,630 | - | 8,630 |
| JG Best | 2,983 | 1,758 | 440 | 169 | 5,350 | - | 5,350 |
| DL Hodgson | 2,983 | 958 | 440 | 45 | 4,426 | - | 4,426 |
| Dr SE Jonah KBE (effective 1 June 2004) | 2,967 | 918 | - | 318 | 4,203 | - | 4,203 |
| KH Williams | 3,089 | 836 | 458 | 104 | 4,487 | 7,179 | 11,666 |
| Total | 17,663 | 6,472 | 2,163 | 798 | 27,096 | 7,179 | 34,275 |
| Executive officers' remuneration 2004 |
| Representing 13 executive officers(3) | 16,131 | 5,553 | 2,094 | 1,377 | 25,155 | 2,178 | 27,333 |
| Executive directors' remuneration 2003 |
| RM Godsell (chief executive officer) | 5,386 | 1,641 | 684 | 120 | 7,831 | - | 7,831 |
| JG Best | 2,862 | 743 | 365 | 53 | 4,023 | 4,932 | 8,955 |
| DL Hodgson | 2,862 | 743 | 365 | 61 | 4,031 | 1,845 | 5,876 |
| KH Williams | 2,972 | 769 | 380 | 102 | 4,223 | 291 | 4,514 |
| Total | 14,082 | 3,896 | 1,794 | 336 | 20,108 | 7,068 | 27,176 |
| Executive officers' remuneration 2003 |
| Representing seven executive officers | 9,624 | 2,941 | 927 | 886 | 14,378 | 6,330 | 20,708 |
| Rounding may result in computational differences. |
| (1) | In order to more accurately disclose remuneration received/receivable by executive directors and executive officers, the tables above include the performance related payments calculated on the year's financial results. The 2003 comparative figures have been restated accordingly. |
| (2) | Includes health care, leave encashment, reimbursement of travel expenses and relocation expenses. |
| (3) | Of the 13 executive officers, five were promoted effective 1 May 2004; two were employed effective 1 July 2004; and one was promoted effective 1 December 2004. Emoluments have only been disclosed from the various effective dates, except for performance related payments to be made in 2005 pertaining to 2004 results which reflects total amount. |
Non-executive directors' remuneration
The following table details fees and allowances paid to non-executive directors
All
figures stated
to the nearest
R000 | 2004(1) | 2003 |
Directors'
fees | Committee
fees | Travel(2)
allowance | Total | Directors'
fees | Committee
fees | Travel
allowance | Total |
| RP Edey (chairman) | 602 | 150 | 75 | 827 | 200 | 130 | 43 | 373 |
| Dr TJ Motlatsi | | | | | | | | |
| (deputy chairman) | 250 | 123 | - | 373 | 150 | 110 | 17 | 277 |
| FB Arisman | 99 | 123 | 52 | 274 | 100 | 75 | 45 | 220 |
| Mrs E le R Bradley | 107 | 137 | - | 244 | 100 | 110 | 17 | 227 |
| CB Brayshaw(3) | 107 | 115 | - | 222 | 100 | 65 | 17 | 182 |
| Dr VK Fung (resigned | | | | | | | | |
| 30 April 2003) | - | - | - | - | 33 | 10 | - | 43 |
| AW Lea | 101 | 37 | 13 | 151 | 100 | 30 | - | 130 |
| WA Nairn | 107 | 123 | - | 230 | 100 | 110 | - | 210 |
| NF Oppenheimer | | | | | | | | |
| (resigned 29 April 2004) | 33 | 10 | - | 43 | 100 | 30 | - | 130 |
| J Ogilvie Thompson | | | | | | | | |
| (resigned 29 April 2004) | 33 | 10 | - | 43 | 100 | 30 | - | 130 |
| SR Thompson (appointed | | | | | | | | |
| 30 April 2004) | 67 | 33 | 26 | 126 | - | - | - | - |
| AJ Trahar | 107 | 37 | - | 144 | 100 | 30 | - | 130 |
| PL Zim (appointed | | | | | | | | |
| 30 April 2004) | 73 | 33 | - | 106 | - | - | - | - |
| Total - non-executive | | | | | | | | |
| directors | 1,686 | 931 | 166 | 2,783 | 1,183 | 730 | 139 | 2,052 |
| Alternates | | | | | | | | |
| DD Barber | - | - | - | - | - | - | 17 | 17 |
| PG Whitcutt | - | - | - | - | - | 15 | - | 15 |
| Total - alternate directors | - | - | - | - | - | 15 | 17 | 32 |
| Grand total | 1,686 | 931 | 166 | 2,783 | 1,183 | 745 | 156 | 2,084 |
| Rounding may result in computational differences |
| (1) | At the annual general meeting of shareholders held on 29 April 2004, shareholders approved an increase in directors' fees with effect from 1 May 2004 as follows: |
| - Chairman | - $130,000 (to 30 April 2004: R200,000) per annum
| | - Deputy chairman | - R300,000 (to 30 April 2004: R150,000) per annum
| | - South African resident directors | - R110,000 (to 30 April 2004: R100,000) per annum
| | - Non-resident directors | - $16,000 (to 30 April 2004: R100,000) per annum |
| (2) | A payment of a travel allowance of $4,000 (effective 1 May 2004) or $2,000 prior to this date, per meeting is made to non-executive directors who travel internationally to attend board meetings. In addition, AngloGold Ashanti is liable for the payment of all travel costs. |
| (3) | In addition, Mr Brayshaw was paid a fee of R15,000 (2003: R15,000) by AGRe Insurance Company Limited, a wholly-owned
subsidiary, as chairman of its audit committee. |
| Executive directors do not receive payment of directors' fees or committee fees. |
Share incentive scheme
Options to subscribe for ordinary shares in the company granted to, and exercised by, executive directors, executive officers and other managers during the year to 31 December 2004 and subsequent to
year-end.
Executive directors, executive officers and other managers
| | RM
Godsell | JG
Best | DL
Hodgson | SE
Jonah | KH
Williams | Total
Directors | Total
Executive
Officers** | Total
Other** | Total
Scheme |
| Granted as at 1 January 2004 |
| Number | | 210,300 | 58,800 | 84,600 | - | 91,100 | 444,800 | 287,860 | 3,187,300 | 3,919,960 |
| Average exercise price per share | -
R | 131.27 | 171.38 | 166.27 | - | 141.00 | 145.22 | 181.80 | 214.16 | 203.96 |
| Granted during the year |
| Number | | 14,000 | 12,000 | 8,000 | 50,000 | 8,000 | 92,000 | 57,600 | 1,051,400 | 1,201,000 |
| Average exercise price per share | -
R | 228.00 | 228.00 | 228.00 | 221.00 | 228.00 | 224.20 | 228.00 | 228.00 | 227.71 |
| Exercised during the year |
| Number | | - | - | - | - | 40,100 | 40,100 | 14,600 | 138,100 | 192,800 |
| Average exercise price per share | -
R | - | - | - | - | 104.00 | 104.00 | 116.20 | 118.88 | 115.58 |
| Average market price per share |
| at date of exercise | -
R | - | - | - | - | 283.03 | 283.03 | 265.39 | 272.16 | 273.91 |
| Pre-tax gain at date of exercise | | - | - | - | - | 7,178,916 | 7,178,916 | 2,178,212 | 21,168,311 | 30,525,439 |
| Average per share | -
R | - | - | - | - | 179.03 | 179.03 | 149.19 | 153.28 | 158.33 |
| Lapsed during the year |
| Number | | - | - | - | - | - | - | - | 111,200 | 111,200 |
| Average exercise price per share | -
R | - | - | - | - | - | - | - | 235.59 | 235.59 |
| Held at 31 December 2004 |
| Number | | 224,300 | 70,800 | 92,600 | 50,000 | 59,000 | 496.700 | 330,860 | 3,989,400 | 4,816,960 |
Average exercise
price per share granted | - R | 137.31 | 180.98 | 171.60 | 221.00 | 177.94 | 163.18 | 192.74 | 220.51 | 212.69 |
| Latest expiry date | | 1 November | 1 November | 1 November | 1 May | 1 November | | 1 November | 1 November | |
| | | 2014 | 2014 | 2014 | 2014 | 2014 | | 2014 | 2014 | |
Subsequent to year-end (to
24 February 2005) Exercised | | | | | | | | | |
| Number | | - | 8,000 | - | - | - | 8,000 | - | 13,800 | 21,800 |
| Average exercise price per share | -
R | - | 108.00 | - | - | - | 108.00 | - | 122.22 | 117.00 |
| Average market price per share at |
| date of exercise | -
R | - | 210.00 | - | - | - | 210.00 | - | 203.00 | 205.57 |
| Pre-tax gain at date of exercise | | - | 816,000 | - | - | - | 816,000 | - | 1,114,748 | 1,930,748 |
| Average per share | -
R | - | 102.00 | - | - | - | 102.00 | - | 80.78 | 88.57 |
| Lapsed |
| Number | | - | - | - | - | - | - | - | - | - |
| Average exercise price per share | -
R | - | - | - | - | - | - | - | - | - |
| Held at 24 February 2005 |
| Number | | 224,300 | 62,800 | 92,600 | 50,000 | 59,000 | 488,700 | 330,860 | 3,975,600 | 4,795,160 |
| Average exercise price per share | -
R | 137.31 | 190.27 | 171.60 | 221.00 | 177.94 | 164.08 | 192.74 | 220.85 | 213.12 |
| Latest expiry date | | 1 November | 1 November | 1 November | 1 May | 1 November | | 1 November | 1 November | |
| | | 2014 | 2014 | 2014 | 2014 | 2014 | | 2014 | 2014 | |
| ** | During the year, six senior managers were promoted to executive officers resulting in 112,460 options at an average strike price of R176.64 per option being transferred from the opening balance under "other" to the opening balance under "executive officers". |
|